30 October 2017
Algorithms are becoming ubiquitous in healthcare as their role in answering complex questions and solving sophisticated problems in research, diagnosis, prognosis, and monitoring increases. In our written evidence to the House of Commons Science and Technology inquiry into their use in decision-making we note:
While recognising that the Information Commissioner’s Office (ICO) has made important steps in providing data controllers with advice as to how to comply with the General Data Protection Regulation (GDPR) transparency requirements, we argue more specific advice is highly desirable to foster good practice, which will require that the ICO should engage with the algorithm development sector. We also point to the In Vitro Diagnostic Devices Regulation (IVDR) as another source of potential regulation, which may be a means of ensuring greater transparency and that the Medicine and Healthcare products Regulation Agency have responsibility for regulation in this area.
Read the full response here